How has Intellia Therapeutics's change in accrued liabilities changed year-over-year?

Intellia Therapeutics's change in accrued liabilities increased by 17.1% year-over-year, from -$14.42M to -$11.95M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Intellia Therapeutics NTLA Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Beam TherapeuticsBEAM

-$16.26M+11.9%

Iovance Biotherapeutics, Inc.IOVA

-$21.04M-1,035%

Viridian Therapeutics, Inc.VRDN

-$23.69M-48.9%

Nektar TherapeuticsNKTR

$2.33M+91.4%

Viking TherapeuticsVKTX

$15.86M+376%

IncyteINCY

-$84.73M-213%

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.13B+106%

Enterprise value$2.08B+100%

P/S32.2×+9.5×

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's change in accrued liabilities?: Intellia Therapeutics (NTLA) reported change in accrued liabilities of -$11.95M in Q1 2026.
How has Intellia Therapeutics's change in accrued liabilities changed year-over-year?: Intellia Therapeutics's change in accrued liabilities increased by 17.1% year-over-year, from -$14.42M to -$11.95M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.